Up-to-date surgery for ulcerative colitis in the era of biologics

References

• Chudy-Onwugaje KO, Christian KE, Farraye FA, et al. A state-of-the-art review of new and emerging therapies for the treatment of IBD. Inflamm Bowel Dis. 2019 Apr 11;25(5):820–830.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Su C, Sands BE, et al. Tofacitinib as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2017 May 4;376(18):1723–1736.
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015 Sep;110(9):1324–1338.
   PubMed Web of Science ®Google Scholar
• Olivera P, Spinelli A, Gower-Rousseau C, et al. Surgical rates in the era of biologic therapy: up, down or unchanged? Curr Opin Gastroenterol. 2017 July;33(4):246–253.
   PubMed Web of Science ®Google Scholar
• Kotze PG, Underwood FE, Damião AOMC, et al. Progression of inflammatory bowel diseases throughout Latin America and the Caribbean: a systematic review. Clin Gastroenterol Hepatol. 2020 Feb;18(2):304–312.
   Web of Science ®Google Scholar
• Kaplan GG, Seow CH, Ghosh S, et al. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. Am J Gastroenterol. 2012 Dec;107(12):1879–1887.
   PubMed Web of Science ®Google Scholar
• Gu J, Stocchi L, Ashburn J, et al. Total abdominal colectomy vs. restorative total proctocolectomy as the initial approach to medically refractory ulcerative colitis. Int J Colorectal Dis. 2017 Aug;32(8):1215–1222.
   PubMed Web of Science ®Google Scholar
• Narula N, Charleton D, Marshall JK. Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013 June;37(11):1057–1064.
   PubMed Web of Science ®Google Scholar
• Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2(4947):1041–1048.
   PubMed Web of Science ®Google Scholar
• Bitton A, Buie D, Enns R, et al.; Canadian Association of Gastroenterology Severe Ulcerative Colitis Consensus Group. Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements. Am J Gastroenterol 2012;107(2):179–194.
   PubMed Web of Science ®Google Scholar
• Dinesen LC, Walsh AJ, Protic MN, et al. The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010;4(4):431–437.
   PubMed Web of Science ®Google Scholar
• Ho GT, Mowat C, Goddard CJ, et al. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther. 2004;19(10):1079–1087.
   PubMed Web of Science ®Google Scholar
• Lynch RW, Churchhouse AM, Protheroe A, et al.; UK IBD Audit Steering Group. Predicting outcome in acute severe ulcerative colitis: comparison of the Travis and Ho scores using UK IBD audit data. Aliment Pharmacol Ther 2016;43(11):1132–1141.
   PubMed Web of Science ®Google Scholar
• Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet. 1974;1(7866):1067–1070.
   PubMed Web of Science ®Google Scholar
• Turner D, Walsh CM, Steinhart AH, et al. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol. 2007;5(1):103–110.
   PubMed Web of Science ®Google Scholar
• Jakobovits SL, Travis SP. Management of acute severe colitis. Br Med Bull. 2006;75–76:131–144.
   PubMed Web of Science ®Google Scholar
• Hart AL, Ng SC. Review article: the optimal medical management of acute severe ulcerative colitis. Aliment Pharmacol Ther. 2010;32(5):615–627.
   PubMed Web of Science ®Google Scholar
• Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330(26):1841–1845.
   PubMed Web of Science ®Google Scholar
• Järnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology. 2005;128(7):1805–1811.
   PubMed Web of Science ®Google Scholar
• Seah D, De Cruz P. Review article: the practical management of acute severe ulcerative colitis. Aliment Pharmacol Ther. 2016;43(4):482–513.
   PubMed Web of Science ®Google Scholar
• Hindryckx P, Novak G, Vande Casteele N, et al. Review article: dose optimisation of infliximab for acute severe ulcerative colitis. Aliment Pharmacol Ther. 2017;45(5):617–630.
   PubMed Web of Science ®Google Scholar
• Dulai PS, Jairath V. Acute severe ulcerative colitis: latest evidence and therapeutic implications. Ther Adv Chronic Dis. 2018;9(2):65–72.
   PubMed Web of Science ®Google Scholar
• Laharie D, Bourreille A, Branche J, et al.; Groupe d’Etudes Thérapeutiques des Affections Inflammatoires Digestives. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet. 2012; 380(9857):1909–1915.
   PubMed Web of Science ®Google Scholar
• Williams JG, Alam MF, Alrubaiy L, et al. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol. 2016;1(1):15–24.
   PubMed Web of Science ®Google Scholar
• Narula N, Marshall JK, Colombel JF, et al. Systematic review and meta-analysis: infliximab or cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids. Am J Gastroenterol. 2016;111(4):477–491.
   PubMed Web of Science ®Google Scholar
• Roberts SE, Williams JG, Yeates D, et al. Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn’s disease: record linkage studies. BMJ. 2007;335(7628):1033.
   PubMedGoogle Scholar
• Randall J, Singh B, Warren BF, et al. Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications. Br J Surg. 2010;97(3):404–409.
   PubMed Web of Science ®Google Scholar
• Zangenberg MS, Horesh N, Kopylov U, et al. Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review. Int J Colorectal Dis. 2017;32(12):1663–1676.
   PubMed Web of Science ®Google Scholar
• Brown SR, Haboubi N, Hampton J, et al.; ACPGBI. The management of acute severe colitis: ACPGBI position statement. Colorectal Dis 2008;10(Suppl 3):8–29.
   PubMed Web of Science ®Google Scholar
• Bregnbak D, Mortensen C, Bendtsen F. Infliximab and complications after colectomy in patients with ulcerative colitis. J Crohns Colitis. 2012;6:281–286.
   PubMed Web of Science ®Google Scholar
• Eshuis EJ, Al Saady RL, Stokkers PC, et al. Previous infliximab therapy and postoperative complications after proctocolectomy with ileum pouch anal anastomosis. J Crohns Colitis. 2013;7:142–149.
   PubMed Web of Science ®Google Scholar
• Ferrante M, D’Hoore A, Vermeire S, et al. Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis. 2009;15:1062–1070.
   PubMed Web of Science ®Google Scholar
• Gainsbury ML, Chu DI, Howard LA, et al. Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis. J Gastrointest Surg. 2011;15:397–403.
   PubMed Web of Science ®Google Scholar
• Kunitake H, Hodin R, Shellito PC, et al. Perioperative treatment with infliximab in patients with Crohn’s disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg. 2008;12:1730–1736.
   PubMed Web of Science ®Google Scholar
• Mor IJ, Vogel JD, da Luz Moreira A, et al. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum. 2008;51: 1202–1207; discussion 7–10.
   PubMed Web of Science ®Google Scholar
• Norgard BM, Nielsen J, Qvist N, et al. Pre-operative use of anti-TNF-alpha agents and the risk of post-operative complications in patients with Crohn’s disease–a nationwide cohort study. Aliment Pharmacol Ther. 2013;37:214–224.
   PubMed Web of Science ®Google Scholar
• Selvasekar CR, Cima RR, Larson DW, et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg. 2007;204:956–962; discussion 62–3.
   PubMed Web of Science ®Google Scholar
• Yang Z, Wu Q, Wang F, et al. Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery. Aliment Pharmacol Ther. 2012;36:922–928.
   PubMed Web of Science ®Google Scholar
• Gu J, Remzi FH, Shen B, et al. Operative strategy modifies risk of pouch-related outcomes in patients with ulcerative colitis on preoperative anti-tumor necrosis factor-α therapy. Dis Colon Rectum. 2013 Nov;56(11):1243–1252.
   PubMed Web of Science ®Google Scholar
• Lau C, Dubinsky M, Melmed G, et al. The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery. Ann Surg. 2015 Mar;261(3):487–496.
   PubMed Web of Science ®Google Scholar
• Cohen B, Fleshner P, Kane SV, et al. Anti-tumor necrosis factor therapy is not associated with post-operative infection: results from prospective cohort of ulcerative colitis and Crohn’s disease patients undergoing surgery to identify risk factors for postoperative infection I (Puccini). Gastroenterology. 2019 May;156(6, Supplement 1):S–80.
   Web of Science ®Google Scholar
• Feagan BG, Rutgeerts P, Sands BE, et al.; GEMINI 1 Study Group. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013 Aug 22;369(8):699–710.
   PubMed Web of Science ®Google Scholar
• Lightner AL, McKenna NP, Moncrief S, et al. Surgical outcomes in vedolizumab treated patients with ulcerative colitis. Inflamm Bowel Dis. 2017 Dec;23(12):2197–2201.
   PubMed Web of Science ®Google Scholar
• Ferrante M, de Buck van Overstraeten A, Schils N, et al. Perioperative use of vedolizumab is not associated with postoperative infectious complications in patients with ulcerative colitis undergoing colectomy. J Crohns Colitis. 2017 Oct 27;11(11):1353–1361.
   PubMed Web of Science ®Google Scholar
• Law CCY, Narula A, Lightner AL, et al. Systematic review and meta-analysis: preoperative vedolizumab treatment and postoperative complications in patients with inflammatory bowel disease. J Crohns Colitis. 2018 Apr 27;12(5):538–545.
   PubMed Web of Science ®Google Scholar
• Yung DE, Horesh N, Lightner AL, et al. Systematic review and meta-analysis: vedolizumab and postoperative complications in inflammatory bowel disease. Inflamm Bowel Dis. 2018 Oct 12;24(11):2327–2338.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Sands BE, Panaccione R, et al. Efficacy and safety of ustekinumab in maintenance therapy in ulcerative colitis: week 44 results from UNIFI. OP 37. ECCO Congress, Copenhagen, Denmark; 2019.
   Google Scholar
• Øresland T, Bemelman WA, Sampietro GM, et al. European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis. 2015;9:4–25.
   PubMed Web of Science ®Google Scholar
• Heuschen UA, Hinz U, Allemeyer EH, et al. Risk factors for ileoanal J pouch-related septic complications in ulcerative colitis and familial adenomatous polyposis. Ann Surg. 2002 Feb;235(2):207–216.
   PubMed Web of Science ®Google Scholar
• Lim WC, Hanauer SB. Emerging biologic therapies in inflammatory bowel disease. R Rev Gastroenterol Disord. 2004 Spring;4(2):66–85.
   PubMedGoogle Scholar
• Heuschen UA, Allemeyer EH, Hinz U, et al. Outcome after septic complications in J pouch procedures. Br J Surg. 2002;89:194–200.
   PubMed Web of Science ®Google Scholar
• Gorfine SR, Fichera A, Harris MT, et al. Long-term results of salvage surgery for septic complications after restorative proctocolectomy: does fecal diversion improve outcome? Dis Colon Rectum. 2003 Oct;46(10):1339–1344.
   PubMed Web of Science ®Google Scholar
• Bikhchandani J, Polites SF, Wagie AE, et al. National trends of 3- versus 2-stage restorative proctocolectomy for chronic ulcerative colitis. Dis Colon Rectum. 2015 Feb;58(2):199–204.
   PubMed Web of Science ®Google Scholar
• Alves A, Panis Y, Bouhnik Y, et al. Subtotal colectomy for severe acute colitis: a 20-year experience of a tertiary care center with an aggressive and early surgical policy. J Am Coll Surg. 2003 Sep;197(3):379–385.
   PubMed Web of Science ®Google Scholar
• Pandey S, Luther G, Umanskiy K, et al. Minimally invasive pouch surgery for ulcerative colitis: is there a benefit in staging? Dis Colon Rectum. 2011 Mar;54(3):306–310.
   PubMed Web of Science ®Google Scholar
• Mège D, Figueiredo MN, Manceau G, et al. Three-stage laparoscopic ileal pouch-anal anastomosis is the best approach for high-risk patients with inflammatory bowel disease: an analysis of 185 consecutive patients. J Crohns Colitis. 2016 Aug;10(8):898–904.
   PubMed Web of Science ®Google Scholar
• Aberra FN, Lewis JD, Hass D, et al. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology. 2003 Aug;125(2):320–327.
   PubMed Web of Science ®Google Scholar
• Miki C, Ohmori Y, Yoshiyama S, et al. Factors predicting postoperative infectious complications and early induction of inflammatory mediators in ulcerative colitis patients. World J Surg. 2007 Mar;31(3):522–529; discussion 530–1.
   PubMed Web of Science ®Google Scholar
• Tontini GE, Vecchi M, Pastorelli L, et al. Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives. World J Gastroenterol. 2015 Jan 7;21(1):21–46.
   PubMed Web of Science ®Google Scholar
• Nicholls RJ, Chir M, Holt SDH, et al. Restorative proctocolectomy with ileal reservoir - comparison of two-stage vs. three-stage procedures and analysis of factors that might affect outcome. Dis Colon Rectum. 1989 Apr;32(4):323–326.
   PubMed Web of Science ®Google Scholar
• Hicks CW, Hodin RA, Bordeianou L. Possible overuse of 3-stage procedures for active ulcerative colitis. JAMA Surg. 2013 July;148(7):658–664.
   PubMed Web of Science ®Google Scholar
• Heuschen UA, Hinz U, Allemeyer EH, et al. One- or two-stage procedure for restorative proctocolectomy rationale for a surgical strategy in ulcerative colitis. Ann Surg. 2001 Dec;234(6):788–794.
   PubMed Web of Science ®Google Scholar
• Remzi FH, Fazio VW, Gorgun E, et al. The outcome after restorative proctocolectomy with or without defunctioning ileostomy. Dis Colon Rectum. 2006 Apr;49(4):470–477.
   PubMed Web of Science ®Google Scholar
• Ikeuchi H, Nakano H, Uchino M, et al. Safety of one-stage restorative proctocolectomy for ulcerative colitis. D Dis Colon Rectum. 2005 Aug;48(8):1550–1555.
   PubMed Web of Science ®Google Scholar
• Hainsworth PJ, Bartolo DCC. Selective omission of loop ileostomy in restorative proctocolectomy. Int J Colorectal Dis. 1998;13(3):119–123.
   PubMed Web of Science ®Google Scholar
• Gorfine SR, Gelernt IM, Bauer JJ, et al. Restorative proctocolectomy without diverting ileostomy. D Dis Colon Rectum. 1995 Feb;38(2):188–194.
   PubMed Web of Science ®Google Scholar
• Lovegrove RE, Symeonides P, Tekkis PP, et al. A selective approach to restorative proctocolectomy without ileostomy: a single centre experience. Colorectal Dis. 2008 Nov;10(9):916–924.
   PubMed Web of Science ®Google Scholar
• Zittan E, Wong-chong N, Ma GW, et al. Modified two-stage ileal pouch-anal anastomosis results in lower rate of anastomotic leak compared with traditional two-stage surgery for ulcerative colitis. J Crohns Colitis. 2016 July;10(7):766–772.
   PubMed Web of Science ®Google Scholar
• Sahami S, Buskens CJ, Fadok TY, et al. Defunctioning ileostomy is not associated with reduced leakage in proctocolectomy and ileal pouch anastomosis surgeries for IBD. J Crohns Colitis. 2016 July;10(7):779–785.
   PubMed Web of Science ®Google Scholar